Moderna, OpenAI Partner for Automation

Moderna is preparing to announce a partnership with OpenAI, aiming to automate nearly every business process at the biotechnology company. This collaboration is anticipated to expand the reach of ChatGPT, a product of OpenAI, into the enterprise sector. As part of the agreement, around 3,000 Moderna employees will have access to ChatGPT Enterprise, which is built on OpenAI's advanced language model, GPT-4, by the end of this week.

The integration of AI into Moderna's processes could potentially speed up the company's plan to introduce 15 new products within the next five years. The specifics of the deal have not been disclosed. Moderna, a digital-first company, has been using machine learning since its inception. This strong data foundation, along with a robust culture of learning, positions the company to integrate generative AI into its operations seamlessly and responsibly.

Moderna has an ambitious plan to launch multiple products over the next few years. Partnerships with companies like OpenAI are seen as crucial to Moderna's ability to scale and maximize its impact on patients. The shared vision of AI's transformative potential in the future of business and healthcare is the driving force behind this ongoing collaboration between Moderna and OpenAI.